GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WntResearch AB (XSAT:WNT) » Definitions » Cash-to-Debt

WntResearch AB (XSAT:WNT) Cash-to-Debt : No Debt (1) (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is WntResearch AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. WntResearch AB's cash to debt ratio for the quarter that ended in Dec. 2023 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, WntResearch AB could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for WntResearch AB's Cash-to-Debt or its related term are showing as below:

XSAT:WNT' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt   Med: No Debt   Max: No Debt
Current: No Debt

During the past 13 years, WntResearch AB's highest Cash to Debt Ratio was No Debt. The lowest was No Debt. And the median was No Debt.

XSAT:WNT's Cash-to-Debt is ranked better than
99.74% of 1540 companies
in the Biotechnology industry
Industry Median: 6.52 vs XSAT:WNT: No Debt

WntResearch AB Cash-to-Debt Historical Data

The historical data trend for WntResearch AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

WntResearch AB Cash-to-Debt Chart

WntResearch AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

WntResearch AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

Competitive Comparison of WntResearch AB's Cash-to-Debt

For the Biotechnology subindustry, WntResearch AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WntResearch AB's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WntResearch AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where WntResearch AB's Cash-to-Debt falls into.



WntResearch AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

WntResearch AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

WntResearch AB had no debt (1).

WntResearch AB's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

WntResearch AB had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WntResearch AB  (XSAT:WNT) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


WntResearch AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of WntResearch AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


WntResearch AB (XSAT:WNT) Business Description

Traded in Other Exchanges
Address
Per Albin Hansson, Road 41, Medeon Science Park, Malmo, SWE, 205 12
WntResearch AB is a cancer research company. The company develops anti-metastatic therapies based on the mechanisms underlying the metastatic process.

WntResearch AB (XSAT:WNT) Headlines

No Headlines